Page 1962 - Markets News

$1-bn outflows: FPIs turn wary of India on worsening coronavirus crisis

Covid-19, US yields, dollar to weigh on equity flows in the near term

Crude oil jumps above $64, marking one year of crash below zero

West Texas Intermediate advanced 1.3 per cent, adding to Monday's modest climb as the dollar weakened, while production in Libya fell below 1 million barrels a day amid a budget dispute

March 2020 lows biggest turning point for Indian markets: Jhunjhunwala

Says current crisis is a temporary blip and India is poised for a long bull market

Sensex drops 243 points to finish at three-month low after see-saw trade

The broader markets witnessed healthy buying interest as both mid-cap and small-cap indices ended higher by 0.5 per cent

Aditya Birla MF files IPO document with Sebi; issue size Rs 2,000 cr

Through the maiden offering Canadian firm Sun Life Financial will divest its 12.56% holding, while Aditya Birla Capital will sell a little less than 1%

Sebi directive of April 1 may put the brakes on MF dividends in FY22

Operational and compliance challenges foreseen for fund houses in deducting tax at source, resulting in possible TDS mismatches and disputes with investors

Near-term margin concerns and valuations weigh on Dr Lal Pathlabs

Some brokerages prefer Metropolis given higher realisation, revenue growth trajectory

Covid second wave unlikely to dent FY22 earnings, say analysts

While there will be some sectors (such as entertainment, hotels, aviation etc.) that will bear the brunt of the second Covid wave, the loss will be compensated by strong earnings in some other sectors

Market Wrap, April 20: Here's all that happened in the markets today

BSE barometer Sensex dropped over 1,000 points from day's high to hit a low of 47,438 in the intra-day trade

Localised lockdowns weigh; Sensex declines 244 points amid volatility

The broader markets, however, managed to duck the bear onslaught and supported the overall market breadth

Macrotech Developers trades above issue price; up 22% from debut day's low

The stock rallied 11% to Rs 514 in the intra-day trade today and is up 22 per cent from its Monday's low of Rs 421 on the BSE.

Pharma index hits record high as govt launches phase 3 of Covid vaccination

Cipla, Gland Pharma, JB Chemicals and Pharma, Max Healthcare, Neuland Lab and Apollo Hospital from BSE Healthcare index hit their respective record highs today

Everest Kanto Cylinder zooms 44% in 2 days; stock hits over 10-year high

Given the acute shortage of oxygen cylinders amid rising Covid-19 cases in India, the company is expected to see volume growth in its medical equipment segment

Subex surges 32% in 2 days ahead of new product launch

The company will be launching the new AI automation platform on Thursday, April 22, 2021 and specific details of the same will be unveiled on the launch day

Up 113% in 4 weeks! This specialty steel stock now trades at 13-year high

Acuite Ratings & Research Limited upgraded the ratings of various credit facilities and exposures of the company with a 'stable' outlook

IPO boom prompts ICICI Bank to make hiring push in investment banking

ICICI plans to add five mid-to-senior level hires in each of the two units, which currently have 130 bankers in total.

Gland Pharma hits new high; stock zooms 92% over issue price

The stock was trading higher for the fourth straight day, up 16 per cent during the period

ICICI Prudential surges 10% on strong performance in March quarter

The company posted a 23 per cent year-on-year growth in new business premium during the January-March quarter (Q4FY21), led by steady traction in both regular and single premium business

Top trading recommendations by Anand Rathi: Buy Dr Reddy's Labs, Bata India

The price pattern is very strong on the technical parameters and Dr Reddy's Labs could outperform once there is more clarification on the developments of vaccine

Stocks to watch: TechM, ACC, Nestle India, 5paisa, Caplin Point, ICICI Pru

Ace investor Ashish Kacholia increased stake in Caplin Point from 1.08 per cent as of December 2020 to 1.16 per cent as of March 2021